A leading academic from the University of Newcastle is among 38 beneficiaries in the latest round of the Australian Government’s Priming Grants, aimed at building international relationships to commercialise ground-breaking research.
The grant will allow Dr Adjanie Patabendige to further explore pharmaceuticals designed to combat the effects of stroke.
Minister for Jobs and Innovation, Senator Michaelia Cash, said Priming Grants showed how fostering industry-led innovation created commercial benefits and inspired job growth.
“These Priming Grants are designed to empower researchers and businesses to work with overseas experts to commercialise their projects. This means more opportunities for Australians to grow their ideas by opening doors to foreign markets, which contributes positively to Australia’s economy and job market,” she said.
Dr Patabendige, an HMRI affiliate, will work with Pharmidex Ltd in the UK to develop pharmaceutical agents that could reduce swelling within the skull after stroke.
The Australian Academy of Technology and Engineering (ATSE) works with the Department of Industry, Innovation and Science to deliver the Priming Grants under the Australian Government’s Global Connections Fund (GCF).
